BioMarin Pharmaceutical Inc. buy BMO Capital Markets
Start price
05.07.23
/
50%
€80.26
Target price
05.07.24
€93.60
Performance (%)
-6.16%
End price
06.07.24
€75.32
Summary
This prediction ended on 06.07.24 with a price of €75.32. With a performance of -6.16%, the BUY prediction by BMO_Capital_Markets finished with a loss. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.079% | -0.079% | -23.691% |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% |
Comments by BMO_Capital_Markets for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $102.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten